Evofem Biosciences Inc's Customers Performance

Name: Evofem Biosciences Inc Customers by Division and Industry - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use

EVFM

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.


EVFM's Source of Revenues		During the corresponding time, Evofem Biosciences Inc saw a revenue deteriorated by -45.43 % year on year, sequentially revenue grew by 192.88 %. While revenue at the Evofem Biosciences Inc 's corporate clients • List of EVFM Customers

for the same period Evofem Biosciences Inc revnue deteriorated by -45.43 % year on year, sequentially revenue grew by 192.88 %.

• List of EVFM Customers

Evofem Biosciences Inc's Business Units

Select the Relationship:

Customers ▼

Select the Category:

Comparison ▼

Customers ▼

Basic Report▼

Evofem Biosciences Inc's Comment on Sales, Marketing and Customers

Evofem Therapeutics focuses on addressing unmet sexual and reproductive health needs of women. Its primary market is the U.S. contraceptive market, which is the largest commercial market globally. The company plans to commercialize its product PHEXX directly in the U.S. and through strategic partnerships or license agreements internationally. One such partnership is with Pharma 1 for the Gulf Cooperative Commission (GCC) and MENA regions, with Pharma 1 expected to launch PHEXX in the UAE in 2026. Evofem's product SOLOSEC, an FDA-approved oral antimicrobial agent for bacterial vaginosis and Trichomonas vaginalis, was relaunched in November 2024. Commercialization efforts for SOLOSEC are focused on the U.S. market and through partnerships like the one with Pharma 1 outside the U.S. Additionally, Evofem aims to leverage its U.S. sales force for business development activities to acquire or in-license additional commercial or launch-ready women’s health products to diversify its revenue streams.

Evofem Biosciences Inc’s Comment on Sales, Marketing and Customers

EVFM's Stock Performance relative to it's Customers

EVFM's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)

COMPANY NAME	MARKET CAP	REVENUES	INCOME	EMPLOYEES
Evofem Biosciences Inc	1.07	20.24	-6.03	29
SUBTOTAL	0.00	0.00	0.00	-

Sources: Evofem Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Evofem Biosciences Inc’s corporate clients.
For your research, we’ve provided 9 tables on Evofem Biosciences Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.